Nanores Partner Spółka z Ograniczoną Odpowiedzialnością (KRS 0000555396, NIP 8982211463) is a Polish company, headquartered in Wrocław, Dolnośląskie voivodeship. Nanores Partner operates in: Scientific research and development (PKD 72.10.Z). Industry: Research and development. The company has been listed in the National Court Register since April 27, 2015. Nanores Partner's most recently reported net revenue was 0 PLN for 2025.
No reported revenue
The company reported no revenue in any available reporting year. This may indicate a non-operating entity.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Business profile - Nanores Partner
Identity
- Name
- Nanores Partner Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- Limited Liability Company (LLC)
- Founded
- April 27, 2015
- Registry status as of
- July 3, 2026
- Latest entry
- July 3, 2026
- Founding act
- 16.04.2015 R. NOTARIUSZ ADAM BILIŃSKI KANCELARIA NOTARIALNA WE WROCŁAWIU, REPERTORIUM A NUMER 1005/2015
Articles of association history (6)
- April 16, 2015: 16.04.2015 R. NOTARIUSZ ADAM BILIŃSKI KANCELARIA NOTARIALNA WE WROCŁAWIU, REPERTORIUM A NUMER 1005/2015
- June 24, 2015: 24.06.2015R., NOTARIUSZ ADAM BILIŃSKI, KANCELARIA NOTARIALNA WE WROCŁAWIU PRZY UL. ŚW. ANTONIEGO 26, REP. A NR 1736/2015; ZMIENIONO BRZMIENIE §14 UMOWY SPÓŁKI.
- January 11, 2018: 11.01.2018R., NOTARIUSZ ADAM BILIŃSKI, KANCELARIA NOTARIALNA WE WROCŁAWIU, REP. A NR 205/2018, ZMIANA: § 6, § 7 I § 15.
- January 14, 2021: 14.01.2021 R., NOTARIUSZ ADAM BILIŃSKI, KANCELARIA NOTARIALNA WE WROCŁAWIU, UL. ŚW. ANTONIEGO 26, REP. A NR 127/2021, ZMIENIONO: §6, §7.
- November 14, 2023: 14.11.2023 R., NOTARIUSZ ADAM BILIŃSKI, KANCELARIA NOTARIALNA WE WROCŁAWIU, UL. ŚW. ANTONIEGO 26, REP. A NR 3807/2023, UCHYLENIE DOTYCHCZASOWEGO TEKSTU UMOWY SPÓŁKI I UCHWALENIE NOWEGO BRZMIENIA.
- April 2, 2026: 02.04.2026 R., NOTARIUSZ ADAM BILIŃSKI, KANCELARIA NOTARIALNA WE WROCŁAWIU, UL. ŚW. ANTONIEGO 26, REP. A NR 942/2026, ZMIENIONO: § 2, § 5, § 6 I § 7 UMOWY SPÓŁKI, UCHWALONO TEKST JEDNOLITY UMOWY SPÓŁKI.
Activities
Other activities
Address and contact
- Address
- UL. BIERUTOWSKA, 57-59, 51-317, WROCŁAW, POLSKA
- Voivodeship
- DOLNOŚLĄSKIE
- District
- WROCŁAW
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-16657-24271-FRJJI-19
Risk and payment profile - Nanores Partner
Credibility rating
55.5 / 100
Average credibility
Insolvency risk
Very low
Low threat
Closure risk
1
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organisational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
5
5/11 yrs
Board changes
4
4/11 yrs
PKD changes
1
1/11 yrs
Name changes
1
1/11 yrs
Data from 11 years of registry activity.
Credibility history
Payment reliability score from 2018–2025
Current: C (56/100)
Trend: stable (+0.5 pts/year)
Moderate payment credibility - the company is able to meet its obligations, but some indicators warrant caution.
Trade credit limit history
Standard limit from 2018–2025
Current: 0 PLN
Safe: 0 PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Nanores Partner
Founded
April 27, 2015
11 years in operation
Legal form
Limited Liability Company (LLC)
Registry: RejP
Headquarters
WROCŁAW
DOLNOŚLĄSKIE
Primary PKD
72.10.Z
Scientific research and development
Share capital
66.8 K PLN
1,228 shares total
Shareholders
3
shareholders
Board
1 person
Proxies: 1
Filed years
8 years
2018–2025 · profitable: 0/8
Registry entries
34
latest: July 3, 2026
Revenue
0 PLN
2025
Net profit
0 PLN
2025
Assets
57.0 K PLN
2025
Equity
55.5 K PLN
2025
Valuation
48.1 K PLN
Low confidence
Low confidence
Board and connected people - Nanores Partner
People holding roles at Nanores Partner according to the Polish National Court Register. Follow a name for that person's full profile and their other companies.
- Jaromir KawęckiPresident of the board
- Paweł Piotr ModrzyńskiPresident of the board, Shareholder, Commercial proxy
- Marcin Lech WielebskiVice president, Shareholder, Commercial proxy
- Ryszard Stanisław WielebskiShareholder
Directories and rankings for this location
Public procurement
Trademarks
Reviews
Rate business credibility - Nanores Partner.
No ratings
Related articles
News
Bioceltix in the final EMA dialogue phase: BCX-CM-J could become Europe's first veterinary cell-therapy drug for dogs
Wrocław-based Bioceltix S.A. (KRS 0000744521) entered Q2 2026 in the final EMA dialogue phase on BCX-CM-J – potentially Europe's first veterinary cell-therapy drug based on mesenchymal stem cells, for dogs with osteoarthritis. Responses to the EMA's final questions are due in May 2026; a CVMP recommendation and marketing authorisation are possible in Q3/Q4 2026. A pre-commercial biotech: it closed 2024 with a PLN 14.9m loss on zero revenue and PLN 33.6m of cash at year-end. Trigon DM maintains a buy rating with a PLN 127.2 price target.
News
Captor Therapeutics: PLN 36m of cash at 30 September 2025, runway to mid-2026 – clinical data versus the cash clock
Wrocław-based Captor Therapeutics S.A. (KRS 0000756383) – a pre-commercial biotech specialising in targeted protein degradation (TPD) – closed Q3 2025 with PLN 36m of cash and grants securing funding to mid-2026. CT-01 (hepatocellular carcinoma) entered Phase I, with the first patient dosed at the Barcelona Clinic Liver Cancer. CT-03, an MCL-1 degrader, is close to clinical entry. Without a new R&D partnership or share issue in 2026, the company will need additional financing.